Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1390777 NEW YORK, NY
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$9,884,112
+$1,543,285 QoQ
Shares Held
265,203
+5.9% QoQ
Ownership
0.275%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 286 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 80% Shared 0% None 20%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. IDYA ranks #68 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in IDYA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,884,112 265,203
2026-03-31 $8,340,827 250,325
2025-12-31 $8,436,494 244,041
2025-09-30 $6,772,566 248,900
2025-06-30 $5,251,781 249,847
2025-03-31 $3,713,211 226,692
2024-12-31 $5,815,883 226,299
2024-09-30 $8,750,996 276,231
2024-06-30 $11,112,030 316,492
2024-03-31 $9,713,405 221,363
2023-12-31 $7,709,009 216,667
2023-09-30 $5,295,875 196,289
2023-06-30 $4,092,947 174,168
2023-03-31 $2,113,059 153,901
2022-12-31 $2,772,977 152,613
2022-09-30 $1,805,453 121,009
2022-06-30 $1,497,700 108,529
2022-03-31 $1,263,417 112,906
2021-12-31 $2,705,219 114,434
2021-09-30 $2,814,656 110,422
2021-06-30 $1,646,979 78,465
2021-03-31 $1,143,651 48,666
2020-12-31 $677,474 48,391
2020-09-30 $516,919 41,156
2020-06-30 $430,150 30,271